REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
08/12/2025
Voltar para busca
Dado oficial do USPTO
WMBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
09/12/2025
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
05/11/2019
Data de registro
08/12/2020
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/12/2020
Última transação
09/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
KR
Examinador
MACFARLANE,JAMES W
Unidade examinadora
L40
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "WMBIO" in a gray stylized font, beneath the design of a stylized tree in brown, comprised of a rounded hexagonal shape with a vertical line ending in thee prongs travelling from the bottom of the hexagonal shape to its middle, and with pointed ovals of different sizes alternating in a circular format around the end of the line within the hexagonal shape, representing the leaves of the tree.
Titulares e representantes
Titulares
Wellmarker Bio Co., LTD.
Representantes
Richard Y. Kim Snell & Wilmer L.L.P.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical agents affecting sensory organs; vaccines; vitamin preparations; nervines in the nature of pharmaceutical preparations to calm the nerves; digestives for pharmaceutical purposes; alcohol for pharmaceutical purposes; pharmaceutical agents for epidermis; biological preparations for medical purposesfor treating cancerdiabetes and skin disorders; biological preparations for veterinary purposesfor treating cancerdiabetesskin disorders; drugs for medical purposesfor treating cancerdiabetesskin disorders; medicinal hair growth preparations; pharmaceuticals for humansfor treating cancerdiabetesskin disorders; pharmaceutical preparations for treating cancerdiabetesskin disorders; veterinary preparations for treating cancerdiabetesskin disorders; pharmaceutical preparations acting on the central nervous systemfor treating cancerdiabetesskin disorders; therapeutic drugs and agents for treating cancerdiabetesskin disorders; antibiotic preparations; implants comprising living tissue; medical diagnostic test strips for biomarker analysisblood analysisurine analysissaliva analysis; bandages for dressings; adhesive bands for medical purposes; materials for dental fillings and for stopping teeth
Classe 42
Research and development of vaccines and medicines; development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical products development; research on the subject of pharmaceuticals; medical product testing; scientific research for medical products; scientific research in the fields of medicinehealth and pharmacology; clinical trialsproduct testing in the field of pharmaceuticals; medical research; medical research in the field of crude medicines; bacteriological research; drug discovery services; clinical testing of medicines in the nature of product testing; industrial research in the fields of medicinehealth and pharmacology; scientific research in the field of pharmacy; testinginspection or research of pharmaceuticalscosmetics or foodstuff; medical and scientific research services in the field of cosmetics; research and development of new products; biotechnology research; genetic research; medical and scientific research involving DNA testing; medical and scientific research and product development in the field of DNA chips; medical and scientific research involving the structural and functional analysis of genomes; DNA screening for scientific research purposes; genetic testing for scientific research purposes; scientific research conducted using databases; medical and scientific research involving molecular analysis; product research and development of technology for biotechnology; consultancy in the field of biotechnology; advisory services relating to biotechnology; biotechnology servicesbiotechnology research; genetic testing for scientific research purposes involving biological information checks; genetic testing for medical research purposes involving biological information checks; product research and development of medical apparatus and instruments for others; providing technical support servicestroubleshooting in the nature of diagnosing problems with medical diagnostic instruments; development of computer software for big data processing; developmentupdating and maintenance of software and database systems; computer programming in the medical field; providing computer software technical support services in the field of medical diagnostics; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/03/2021
FIMP
FINAL DISPOSITION PROCESSED
13/03/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/03/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/09/2020
PUBO
PUBLISHED FOR OPPOSITION
22/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/07/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/07/2020
RFNT
REFUSAL PROCESSED BY IB
27/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/03/2020
RFRR
REFUSAL PROCESSED BY MPU
12/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/02/2020
CNRT
NON-FINAL ACTION WRITTEN
19/02/2020
DOCK
ASSIGNED TO EXAMINER
09/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
17/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/12/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WMBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.